Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The LAVA (Lateral Flow Antigen Validation and Applicability) Study for COVID-19

NCT04629157 is registered in ClinicalTrials.gov with Alder Hey Children's NHS Foundation Trust as lead sponsor.

NCT NCT04629157
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04629157 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The LAVA (Lateral Flow Antigen Validation and Applicability) Study for COVID-19
Lead sponsor
Alder Hey Children's NHS Foundation Trust
Phase
Not applicable
Overall status
Completed
Start date
November 5, 2020
Completion date
February 1, 2021
Enrollment
400 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, this is a pilot study which aims to assess the validity and applicability of lateral flow assays (lfas) which can be used as a point of care test for covid-19